| |
 |
|
Class Information
Number: 435/334
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof > Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) > Binds a receptor (e.g., transferrin receptor, fc receptor, dihydropyridine receptor, il-2 receptor, etc.)
Description: Subject matter involving an animal cell which produces a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a free or microorganism-associated receptor.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7592439 |
Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
Sep. 22, 2009 |
| 7575923 |
CD19xCD3 specific polypeptides and uses thereof |
Aug. 18, 2009 |
| 7572594 |
Screening assays for agonists or antagonists or receptor activator of NF-.kappa.B |
Aug. 11, 2009 |
| 7572595 |
Method for searching myelin using gonadotropin-releasing hormone receptors as a new biomarker |
Aug. 11, 2009 |
| 7569387 |
Antibody to TNF receptor-like molecules |
Aug. 4, 2009 |
| 7569675 |
High affinity monoclonal antibody for recognizing the progesterone receptor (PR) and method for creating the antibody |
Aug. 4, 2009 |
| 7547438 |
CD40-binding activating antibodies |
Jun. 16, 2009 |
| 7537763 |
Anti-CD40 monoclonal antibody |
May. 26, 2009 |
| 7476383 |
Antibody selective for DR4 and uses thereof |
Jan. 13, 2009 |
| 7473564 |
Kit and method for detecting the ESM-1 protein |
Jan. 6, 2009 |
| 7445780 |
Antagonistic anti-CD40 antibodies |
Nov. 4, 2008 |
| 7427495 |
Methods of using Bcl-2 for the therapeutic treatment and prevention of diseases |
Sep. 23, 2008 |
| 7425447 |
Host cells expressing 7C10 and 16C10 CD80-specific antibodies |
Sep. 16, 2008 |
| 7425421 |
Method for the enumeration of micronucleated erythrocyte populations while distinguishing platelets and/or platelet-associated aggregates |
Sep. 16, 2008 |
| 7405275 |
Antibodies which bind human CXCR3 |
Jul. 29, 2008 |
| 7393650 |
Method of producing an antibody to G-protein parathyroid hormone receptor HLTDG74 |
Jul. 1, 2008 |
| 7393934 |
Human G-protein chemokine receptor (CCR5) HDGNR10 |
Jul. 1, 2008 |
| 7387895 |
Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseas |
Jun. 17, 2008 |
| 7381412 |
Anti-TECK antibodies and methods of use therefor |
Jun. 3, 2008 |
| 7381560 |
Expression and use of anti-CD20 antibodies |
Jun. 3, 2008 |
| 7371574 |
Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
May. 13, 2008 |
| 7361345 |
Anti-CD40 antibodies capable of blocking B-cell activation |
Apr. 22, 2008 |
| 7357927 |
Death domain containing receptors |
Apr. 15, 2008 |
| 7309489 |
Mouse CD40 ligand-specific antibodies and hybridomas |
Dec. 18, 2007 |
| 7264965 |
Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means |
Sep. 4, 2007 |
| 7252994 |
Human DR4 antibodies and uses thereof |
Aug. 7, 2007 |
| 7244429 |
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
Jul. 17, 2007 |
| 7223844 |
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes |
May. 29, 2007 |
| 7193064 |
Anti-CD40 monoclonal antibody |
Mar. 20, 2007 |
| 7148332 |
High affinity monoclonal antibody for recognizing the estrogen receptor (ER) and method for creating the antibody |
Dec. 12, 2006 |
| 7112661 |
Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha |
Sep. 26, 2006 |
| 7101962 |
Antibodies of the P2Y10 receptor useful in altering T lymphocyte function |
Sep. 5, 2006 |
| 7087396 |
Monoclonal antibody and method and kit for immunoassay of soluble human ST2 |
Aug. 8, 2006 |
| 7071231 |
Naphthalene ureas as glucose uptake enhancers |
Jul. 4, 2006 |
| 7063845 |
Human anti-CD40 antibodies |
Jun. 20, 2006 |
| 7041499 |
Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth |
May. 9, 2006 |
| 7038018 |
Antibodies and ligands for "Bonzo" chemokine receptor |
May. 2, 2006 |
| 7030225 |
Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
Apr. 18, 2006 |
| 7022521 |
Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
Apr. 4, 2006 |
| 7015023 |
Compositions and methods for detection of active proteases |
Mar. 21, 2006 |
| 7005503 |
Human monoclonal antibody against coreceptors for human immunodeficiency virus |
Feb. 28, 2006 |
| 6987171 |
Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
Jan. 17, 2006 |
| 6972125 |
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith |
Dec. 6, 2005 |
| 6951645 |
Monoclonal antibodies recognizing human platelet membrane glycoproteins and use thereof in anti-thrombotic therapy |
Oct. 4, 2005 |
| 6943020 |
Death domain containing receptor-4 antibodies |
Sep. 13, 2005 |
| 6919078 |
Antibodies to human tumor necrosis factor receptor TR9 |
Jul. 19, 2005 |
| 6916628 |
Method for the measurement of soluble CD14 proteins separately |
Jul. 12, 2005 |
| 6913894 |
Antibodies directed against signal regulator proteins |
Jul. 5, 2005 |
| 6893813 |
Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy |
May. 17, 2005 |
|
|
|
